darunavir

The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1). It is used in combination with other antiretroviral agents and specific substances (ritonavir or cobicistat) that enhance its efficacy.

Form: tablets, film-coated

ATC: J05AE10

Manufacturer: Hetero Labs Limited

The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1). It is used in combination with low-dose ritonavir and other antiretroviral agents.

Form: tablets, film-coated

ATC: J05AE10

Manufacturer: Hetero Labs Limited

The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1), in combination with other antiretroviral agents and a pharmacokinetic enhancer (ritonavir or cobicistat).

Form: tablets, film-coated

ATC: J05AE10

Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo Mesto (batch control (only physical and chemical control methods))

The drug is intended for the treatment of people with HIV-1 infection. It is used in both adults and children aged 12 years and older weighing at least 40 kg.

Form: tablets, film-coated

ATC: J05AE10

Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo Mesto (batch control (only physical and chemical control methods))

The drug is intended for the treatment of patients infected with the human immunodeficiency virus (HIV-1), in combination with low-dose ritonavir and other antiretroviral agents.

Form: tablets, film-coated

ATC: J05AE10

Manufacturer: KRKA, d.d., Novo Mesto (manufacturing "in bulk", primary and secondary packaging, quality control and batch release) / KRKA, d.d., Novo Mesto (batch control (only physical and chemical control methods))